Ozempic: How Does It Work?Endocrinologist Explains
A short interview in which an endocrinologist explains how Ozempic (semaglutide) works, who it is approved for, how long it is used, other GLP-1 options and common side effects.
With Dr. Bradwin, Dr. Paul Zalzo, Dr. Chen (endocrinologist)
Key moments
Tap a moment to play the video from there.
- 0:31Why Ozempic is a hot topicThe hosts introduce Ozempic as a trending subject on social media, and the guest begins by explaining what the drug is.
- 1:02The gut hormone being mimickedDr. Chen says semaglutide imitates GLP-1, which the gut releases after eating and which signals the pancreas to raise insulin and lower glucagon.
- 1:34Stomach emptying and fullnessThe guest says the hormone slows stomach emptying and signals the brain, so people feel full sooner. A buffet and stretchy pants are used as an analogy.
- 3:05Diabetes drug versus obesity drugThe guest says Ozempic is a weekly injection approved for type 2 diabetes, while semaglutide at higher doses has been studied for obesity and sold under another name.
- 4:06Supply and off-label useThe hosts discuss how supply problems with the obesity product may have pushed doctors to prescribe Ozempic off label. The guest says Canada has not seen the same shortage.
- 4:36How well does it workDr. Chen reports lower sugar, weight and blood pressure in patients, plus evidence for fewer heart attacks and strokes in people with type 2 diabetes.
- 6:07Is it a lifelong medicationThe guest says type 2 diabetes and obesity are chronic, so the drug manages them rather than curing them, and effects fade when it is stopped.
- 7:07Other GLP-1 optionsThe guest lists Trulicity as another weekly injection and Rybelsus as an oral semaglutide, and says daily injections are used less often.
- 8:09Side effects and dosesDr. Chen says nausea, vomiting, diarrhea and constipation are the main class side effects, often temporary, and that dose adjustments can reduce them.
- 8:39Talk to your doctorThe hosts close by encouraging viewers to work out an individual plan with their physician and to try lifestyle changes first.
What the video says
This episode of Talking With Docs is a nine-minute conversation between two hosts and a guest endocrinologist, Dr. Chen, about Ozempic. The hosts note that the drug is a hot topic on social media, and the guest starts with the basics. Ozempic is the brand name for semaglutide, which belongs to the GLP-1 receptor agonist class. According to the guest, it mimics a hormone the gut releases after eating. That hormone signals the pancreas to raise insulin and lower glucagon, tells the stomach to empty more slowly, and tells the brain that food has arrived. The guest says people with type 2 diabetes have a problem in this system, and giving the hormone back at high levels strengthens those effects.
The guest stresses that Ozempic is a once weekly injection approved for type 2 diabetes, not for weight loss. The same drug has been studied for obesity at higher doses and is sold under a different brand name for that purpose, which the auto captions render unclearly. The hosts raise supply problems with the obesity product and say that is one reason Ozempic became popular, and the guest adds that the obesity version was not yet commercially available in Canada at the time of recording.
On effectiveness, Dr. Chen calls it a very good drug for its intended use and says patients see lower blood sugar, lower weight and lower blood pressure. The guest also says the class has evidence of fewer heart attacks, strokes and cardiovascular deaths, but only in people with type 2 diabetes who have cardiovascular disease or several risk factors. The guest says the mechanism is not fully understood. The guest describes the drug as a long-term management tool rather than a cure, comparing stopping it to releasing a brake, so the effects fade.
The last third covers alternatives and safety. Dr. Chen names another weekly injection (Trulicity, or dulaglutide) and an oral form of semaglutide (Rybelsus), and says weekly dosing is preferred over daily. Nausea, vomiting, diarrhea and constipation are the main side effects for the class, which the guest says affect about 20 percent of people and are usually transient. The hosts close by urging viewers to talk to their own doctor.
On each compound
Semaglutide1:02
Dr. Chen explains that semaglutide, sold as Ozempic, mimics the gut hormone GLP-1 and is approved as a once weekly injection for type 2 diabetes. The guest describes benefits for sugar, weight, blood pressure and cardiovascular outcomes in people with diabetes, and says nausea and vomiting occur in about 20 percent of people.
See how your DNA reads Semaglutide“lifestyle first and then if that's not working”
What this video doesn’t settle
- The guest says the mechanism behind the reported heart and stroke benefits is not fully understood.
- The cardiovascular evidence described applies to people with type 2 diabetes, and the video does not establish effects in the general population.
- No study names, trial data or dose figures are given, so the claims about effectiveness rest on the guest's clinical summary.
Questions this video answers
How does Ozempic work according to an endocrinologist?
Dr. Chen says Ozempic (semaglutide) mimics GLP-1, a hormone the gut releases after eating. It signals the pancreas to raise insulin, slows stomach emptying and tells the brain that food has arrived, so people feel full sooner.
Is Ozempic approved for weight loss?
The guest says Ozempic is a once weekly injection approved for type 2 diabetes. Semaglutide at higher doses has been studied for obesity and is approved under a different brand name for that use.
Do you have to stay on Ozempic forever?
Dr. Chen says type 2 diabetes and obesity are chronic conditions and the drug manages them without curing them. When it is stopped, the guest says, blood sugar and weight can come back, though there are other ways to manage diabetes.
What are the side effects of Ozempic mentioned in this video?
The guest names nausea, vomiting, diarrhea and constipation as the main side effects for the whole drug class. Dr. Chen says nausea and vomiting affect about 20 percent of people, usually pass over time, and can be eased by adjusting the dose.
What other drugs work like Ozempic?
Dr. Chen mentions Trulicity (dulaglutide), another weekly injection, and Rybelsus, an oral form of semaglutide. The guest says daily GLP-1 injections exist but are used less because weekly options are available.
Video by Talking With Docs on YouTube, embedded as published. The summary is written by PeptidesDNA from the video; every claim in it is the speaker’s. Not affiliated with or endorsed by the creator. Not medical advice.
